Results 181 to 190 of about 72,559 (229)
Some of the next articles are maybe not open access.
Vancomycin-Resistant Enterococci
Critical Care Clinics, 2013Vancomycin-resistant enterococci (VRE) consist mainly of Enterococcus faecalis and E faecium, the latter mostly hospital-acquired. In addition, E gallinarum and E casseliflavus are intrinsically vancomycin-resistant and are community-acquired. VRE have become common in many hospitals throughout the world and, once established, are very difficult to ...
Ethan, Rubinstein, Yoav, Keynan
openaire +2 more sources
VANCOMYCIN-RESISTANT ENTEROCOCCI
Clinics in Podiatric Medicine and Surgery, 1996The enterococcus has emerged as one of the most important nosocomial pathogens: an organism with the ability to develop resistance to all available antibiotics. This article details the historic significance of the enterococcus and delineates the clinical presentations and therapeutic options for the clinician.
K, Thakor, A E, Glatt
openaire +4 more sources
VANCOMYCIN-RESISTANT ENTEROCOCCI
The Lancet, 1988Enterococci, a part of normal gut flora, are not particularly pathogenic organisms in humans. For example, they do not cause respiratory tract infections. The most frequent enterococcal infections are urinary tract infections. Despite their lack of pathogenicity, enterococci have emerged as significant nosocomial pathogens in the United States and ...
A H, Uttley +3 more
openaire +2 more sources
Vancomycin-resistant enterococci
The American Journal of Medicine, 1997Enterococci have been recognized as an important cause of nosocomial infections for almost 20 years and as a cause of endocarditis for almost a century. While long known for their capacity of displaying multiple antibiotic resistant traits, the extent to which this could occur was not fully appreciated until the emergence of enterococci with acquired ...
openaire +2 more sources
Antibiotic-resistant enterococci
Journal of Hospital Infection, 1992Enterococci have emerged as an important cause of nosocomial infection. Successful antibiotic treatment of serious enterococcal infection usually depends on the synergistic bactericidal effect achieved by the combination of a cell wall-active agent, such as ampicillin or a glycopeptide, and an aminoglycoside.
J W, Gray, S J, Pedler
openaire +2 more sources
International Journal of Antimicrobial Agents, 2007
Besides Staphylococcus aureus, other Gram-positive bacteria have become multidrug-resistant and cause therapeutic problems, particularly amongst hospitalised patients. The acquisition of vancomycin resistance by strains of Enterococcus faecium and Enterococcus faecalis is of particular concern and has resulted in treatment failures.
openaire +2 more sources
Besides Staphylococcus aureus, other Gram-positive bacteria have become multidrug-resistant and cause therapeutic problems, particularly amongst hospitalised patients. The acquisition of vancomycin resistance by strains of Enterococcus faecium and Enterococcus faecalis is of particular concern and has resulted in treatment failures.
openaire +2 more sources